Multiple endocrine neoplasia: an update.
genetics
multiple endocrine neoplasia
screening
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
04
04
2019
revised:
22
05
2019
accepted:
29
05
2019
entrez:
7
8
2019
pubmed:
7
8
2019
medline:
10
4
2020
Statut:
ppublish
Résumé
The multiple endocrine neoplasia (MEN) syndromes include MEN1, MEN2 (formerly MEN2A), MEN3 (formerly MEN2B) and the recently identified MEN4. Clinical presentations are varied and often relate to the overproduction of specific hormones. Understanding the genetics of each syndrome assists in determining screening timelines. Treatments for each manifestation are dependent on location, risk of recurrence or malignancy, hormone excess and surgical morbidity. Multidisciplinary management should include geneticists, genetic counsellors, endocrinologists and endocrine surgeons.
Substances chimiques
Genetic Markers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
954-961Informations de copyright
© 2019 Royal Australasian College of Physicians.